The Linear-Quadratic Model Is Inappropriate to Model High Dose per Fraction Effects in Radiosurgery
about
Big Data Analytics for Prostate RadiotherapyThe Role of Hypofractionated Radiation Therapy with Photons, Protons, and Heavy Ions for Treating Extracranial LesionsRadiobiological mechanisms of stereotactic body radiation therapy and stereotactic radiation surgeryThe tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved?Are three doses of stereotactic ablative radiotherapy (SABR) more effective than 30 doses of conventional radiotherapy?The biology of radiosurgery and its clinical applications for brain tumors.Stereotactic body radiotherapy for oligo-recurrence within the nodal area from colorectal cancerTreatment of Breast and Prostate Cancer by Hypofractionated Radiotherapy: Potential Risks and BenefitsRadiobiology of radiosurgery for the central nervous systemRadiotherapy and the tumor stroma: the importance of dose and fractionationIn silico analysis of cell cycle synchronisation effects in radiotherapy of tumour spheroidsEquivalence of cell survival data for radiation dose and thermal dose in ablative treatments: analysis applied to essential tremor thalamotomy by focussed ultrasound and gamma knife.Clinical practice of image-guided spine radiosurgery--results from an international research consortium.Radiosurgery with photons or protons for benign and malignant tumours of the skull base: a review.Bioinformatics methods for learning radiation-induced lung inflammation from heterogeneous retrospective and prospective dataCerebral cyst formation following stereotactic ablative irradiation for non-nasopharyngeal head and neck malignancies: imaging findings and relevant dosimetric parameters.Normal tissue studies in radiation oncology: A systematic review of highly cited articles and citation patterns.Radiation therapy for liver tumors: ready for inclusion in guidelines?Can drugs enhance hypofractionated radiotherapy? A novel method of modeling radiosensitization using in vitro dataRe-irradiation: outcome, cumulative dose and toxicity in patients retreated with stereotactic radiotherapy in the abdominal or pelvic regionAggressive local treatment containing intraoperative radiation therapy (IORT) for patients with isolated local recurrences of pancreatic cancer: a retrospective analysis.Recurrent malignant gliomas.A Phase II Trial of Stereotactic Ablative Body Radiotherapy for Low-Risk Prostate Cancer Using a Non-Robotic Linear Accelerator and Real-Time Target Tracking: Report of Toxicity, Quality of Life, and Disease Control Outcomes with 5-Year Minimum FollDifferences in rates of radiation-induced true and false rib fractures after stereotactic body radiation therapy for Stage I primary lung cancer.Tenascin-C: Exploitation and collateral damage in cancer managementWhole brain radiotherapy with adjuvant or concomitant boost in brain metastasis: dosimetric comparison between helical and volumetric IMRT techniqueLong-term outcome and toxicity of hypofractionated stereotactic body radiotherapy as a boost treatment for head and neck cancer: the importance of boost volume assessment.Local and Global Function Model of the LiverClinical outcome of stereotactic body radiotherapy for primary and oligometastatic lung tumors: a single institutional study with almost uniform dose with different five treatment schedules.Datamining approaches for modeling tumor control probability.Hypofractionated external-beam radiotherapy for prostate cancer.Perfusion and Volume Response of Canine Brain Tumors to Stereotactic Radiosurgery and RadiotherapyStereotactic body radiotherapy for lesions of the spine and paraspinal regionsSafety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas.Impact of Fractionation and Dose in a Multivariate Model for Radiation-Induced Chest Wall Pain.Lung stereotactic ablative radiotherapy (SABR): dosimetric considerations for chest wall toxicityDefinition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancer.The biological effect of large single doses: a possible role for non-targeted effects in cell inactivation.Dose escalation of Stereotactic Body Radiotherapy (SBRT) for locally advanced unresectable pancreatic cancer patients with CyberKnife: protocol of a phase I study.Intraoperative radiation therapy (IORT) in pancreatic cancer.
P2860
Q26744485-54900713-0F39-481B-A1CE-A28BAD2B0F0FQ26770254-5C92CC61-10BF-4891-997A-5B75376CCC29Q26772259-BABD7226-2055-4B1E-9A5A-8822E90E7BFFQ26823489-8A5D0066-27C0-48FE-9C82-BA49A6C83865Q26823670-E128269B-4933-4452-A425-E1D01B574184Q26829154-71A3ACBA-3C0C-4C04-9CCD-91A2AD1DDE1CQ26866335-A6123C0C-35D2-4E83-97A2-A8CE500DE37DQ26998991-951E69B9-10F1-483F-939A-AD93407D3EEEQ27011342-3BD8D1D7-3D4B-4BFE-BFF6-6A123BD25FD8Q27022685-CAB5AC27-E887-41AD-AF32-CD9CB59DE49FQ28535111-9E6EEA00-4EEA-4C2A-B5F4-F198EE85DBE5Q30275112-C65CBB3D-FAAD-4263-90C4-CCCE4DEC5F11Q30428253-368F6429-A462-419D-87B4-84BB764FE0BCQ30458887-8598694B-C7A9-4F67-A44A-A4C1F0ED6942Q33496450-962A4AC1-D5C1-400B-A060-A7D871ADC020Q33823077-0D75E6BC-6EC6-49AA-868C-861CC2E79A15Q33967649-ECFDDE22-C095-490D-8BB7-8D295B22E27BQ34005194-6848CFEA-EAF3-453C-902E-2E822ADF4118Q34134930-D78C2B5C-B3CC-4E44-8D42-9A8B17578E9FQ34262254-2E4F75E6-E31D-4744-9786-DB04C3597F00Q34342960-550E6A00-FB11-4C70-9ED9-FB9F435E68F8Q34438507-BB8CED29-E3B5-4185-B7A9-182E2AE976B2Q34510485-2CC74DA1-A469-4249-8E95-91B5FEE3F70CQ35234046-EDB03B16-94CD-4F21-950F-78705CD9553AQ35577959-B0605FA1-0C7C-4288-B92E-E9EACBEC6D19Q35994140-53782970-4546-4B02-9AB0-FB749885947AQ36143371-3C45AF3D-0260-4D22-B421-A28A278E6899Q36407143-43BF1AF9-A881-4C99-9E7C-039AC26DD90CQ36481633-03DB14AE-17FE-4508-BBB1-C1D05160E03FQ36672792-F00D481E-2367-4D20-9B0A-45861E23B604Q36711751-A7171223-F27C-49E7-9512-4DC509145F53Q36902053-A2835721-CAE6-4C81-98C8-50895CD2CD92Q36915978-A80BD480-1A65-43B2-AA40-BE9036FAE718Q36949475-13F264BF-63EC-4A84-BED5-5FB5F91F1721Q36949855-AB425017-05C3-451B-AA13-02E136C32964Q37175657-92B8D57C-F07A-42B9-A216-6441459C781EQ37468265-3F17E15A-DE1C-4AFE-B1E1-A16BA6F538DFQ37504688-41D6C36D-6550-4C07-A308-02846BF82E75Q37576315-50671407-F0A1-45D1-B4ED-3DEE7E594071Q37576549-F12EB746-76E9-4F66-AFBE-A1C027F353E1
P2860
The Linear-Quadratic Model Is Inappropriate to Model High Dose per Fraction Effects in Radiosurgery
description
article
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2008
@uk
name
The Linear-Quadratic Model Is ...... action Effects in Radiosurgery
@en
The Linear-Quadratic Model Is ...... action Effects in Radiosurgery
@nl
type
label
The Linear-Quadratic Model Is ...... action Effects in Radiosurgery
@en
The Linear-Quadratic Model Is ...... action Effects in Radiosurgery
@nl
prefLabel
The Linear-Quadratic Model Is ...... action Effects in Radiosurgery
@en
The Linear-Quadratic Model Is ...... action Effects in Radiosurgery
@nl
P1476
The linear-quadratic model is ...... action effects in radiosurgery
@en
P2093
Jeffrey J Meyer
Lawrence B Marks
P304
P356
10.1016/J.SEMRADONC.2008.04.005
P577
2008-10-01T00:00:00Z